Skip to content

News

Robotics sector goes full throttle for self-reliance despite headwinds

A visitor captures images of a humanoid robot performing calligraphy during the 2025 Zhongguancun Forum in Beijing on Thursday. WANG JING/CHINA DAILY With breakthroughs in critical technologies, China’s robotics industry is gaining significant momentum as it strides ahead, experts and industry insiders have said. Qiao Hong, an academician at the Chinese Academy of Sciences and…

China’s tech advances boon for global firms

China is emerging as an innovation-centric economy, with technological advances setting the stage for global shifts, while foreign companies can leverage their expertise around the world to help Chinese businesses bolster digital transformation, said Samantha Zhu, chairperson of Accenture Greater China. “For businesses in China looking to boost their productivity and maintain competitiveness, technologies led…

Duty-free curb called ‘self-defeating’

Shein and Temu logos are seen in this illustration taken on Aug 22. [Photo/Agencies] The Trump administration’s latest tariff policy to cancel tax exemptions on low-value packages from China will disrupt the international trade order and increase costs for US consumers, according to Chinese industry associations and experts. The policy to end the de minimis…

China counters US tariffs

China fired off a sweeping package of robust countermeasures on Friday — including a 34 percent tariff hike and rare earth export controls — in response to the latest round of sweeping tariffs adopted by the administration of United States President Donald Trump. More forceful and precise counterstrikes are still in Beijing’s pocket if Washington…

China opens probe into DuPont for alleged monopolistic practices

The DuPont’s logo. [Photo/VCG] The State Administration for Market Regulation, China’s top market regulator, announced on Friday night that it has launched an investigation into DuPont China Group, a subsidiary of the US firm DuPont, for suspected monopolistic practices in violation of China’s Anti-Monopoly Law. The move came as China launched on Friday at least…

EU current account surplus €113.2 bn

{ if (configuration.isSticky) { fragmentElement.style.height = ‘100%’; // Set the height of the fragment element if sticky configuration is enabled } const parentRow = fragmentElement.closest(‘.row, .ecl-row’); // Find the closest parent row element const selector = buildSelector(configuration); // Build the CSS selector based on configuration const headings = Array.from(parentRow.querySelectorAll(selector)); // Get all headings within the…

Household saving rate stable at 15.3% in the euro area

{ if (configuration.isSticky) { fragmentElement.style.height = ‘100%’; // Set the height of the fragment element if sticky configuration is enabled } const parentRow = fragmentElement.closest(‘.row, .ecl-row’); // Find the closest parent row element const selector = buildSelector(configuration); // Build the CSS selector based on configuration const headings = Array.from(parentRow.querySelectorAll(selector)); // Get all headings within the…

Sports goods and services prices rose slower in 2024

label”).text(“Enter search term”); } }); ]]> Search by keyword Enter search term Search = 768 ? true : false; /* Set the width of the sidebar to 250px and the left margin of the page content to 250px */ function openNav() { if(screen.width >= 768){ $(“#facets”).css(“width”, “30%”); $(“#search-results-container”).css(“width”, “69.9%”); $(“#search-results-container”).css(“padding-left”, “3%”); } else { $(“#facets”).css(“width”,…

Nivea Shanghai to start mass production of anti-spot product in July

NIVEA products are on display at a retail counter in Changzhou, Jiangdu province, on Oct 6, 2024. [Photo/VCG] Nivea, using its parent company Beiersdorf’s patented anti-spot ingredient Thiamidol 630, will start mass production of its new product in its Shanghai facility in July, with roll out to the market expected two months later. The announcement…

China’s medical reform fasttracks innovation: US pharma giant

BEIJING – China’s reform efforts to promote research and development on medical innovation and shorten the review and approval time for the launch of related drugs have provided innovation-driven pharmaceutical firms with greater opportunities, a senior executive with US medicine giant Eli Lilly and Company said. “Related reforms have stimulated innovation in the pharmaceutical sector,…